midodrine has been researched along with Renal Insufficiency, Chronic in 1 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Midodrine is widely used in the treatment of hypotensive states, there have been no reports of myoclonus associated with midodrine use in hypotension with chronic kidney disease." | 7.96 | Case report: severe myoclonus associated with oral midodrine treatment for hypotension. ( Chen, M; Ling, B; Ren, Y; Song, F; Wu, J; Wu, S; Xuan, Z; Ye, X; Zhang, H, 2020) |
| "Midodrine is widely used in the treatment of hypotensive states, there have been no reports of myoclonus associated with midodrine use in hypotension with chronic kidney disease." | 3.96 | Case report: severe myoclonus associated with oral midodrine treatment for hypotension. ( Chen, M; Ling, B; Ren, Y; Song, F; Wu, J; Wu, S; Xuan, Z; Ye, X; Zhang, H, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ye, X | 1 |
| Ling, B | 1 |
| Wu, J | 1 |
| Wu, S | 1 |
| Ren, Y | 1 |
| Zhang, H | 1 |
| Song, F | 1 |
| Xuan, Z | 1 |
| Chen, M | 1 |
1 other study available for midodrine and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Case report: severe myoclonus associated with oral midodrine treatment for hypotension.
Topics: Administration, Oral; Adrenergic alpha-1 Receptor Agonists; Female; Humans; Hypotension; Middle Aged | 2020 |